|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest-bearing deposits with financial institutions | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Interest-bearing time deposits with financial institutions | ||||||||||||||||||||
| Investments held-to-maturity, at amortized cost (fair value of $19,820 and $25,013 as of June 30, 2021 and December 31, 2020, respectively) | ||||||||||||||||||||
| Investments securities held-to-maturity, at amortized cost, net of allowance for credit losses of $103 and $110 (fair value of $1,377,903 and $1,428,077) at June 30, 2025 and December 31, 2024, respectively | ||||||||||||||||||||
| Investment securities available-for-sale, at fair value | ||||||||||||||||||||
| FHLB, FRB, and other stock | ||||||||||||||||||||
| Loans held for sale, at lower of cost or fair value | ||||||||||||||||||||
| Loans held for investment | ||||||||||||||||||||
| Allowance for credit losses | ||||||||||||||||||||
| Loans held for investment, net | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Other real estate owned | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Deferred income taxes, net | ||||||||||||||||||||
| Bank owned life insurance | ||||||||||||||||||||
| Intangible assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Deposit accounts: | ||||||||||||||||||||
| Noninterest-bearing checking | ||||||||||||||||||||
| Interest-bearing: | ||||||||||||||||||||
| Checking | ||||||||||||||||||||
| Money market/savings | ||||||||||||||||||||
| Retail certificates of deposit | ||||||||||||||||||||
| Wholesale/brokered certificates of deposit | ||||||||||||||||||||
| Total interest-bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| FHLB advances and other borrowings | ||||||||||||||||||||
| Subordinated debentures | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Preferred stock, $0.01 par value; 1,000,000 authorized; no shares issued and outstanding | ||||||||||||||||||||
| Common stock, $0.01 par value; 150,000,000 shares authorized at June 30, 2025 and December 31, 2024; 97,019,910 shares and 96,441,667 shares issued and outstanding, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
